Rupali Life Insurance Company Limited (DSE:RUPALILIFE)

Verve Therapeutics Ratios and Metrics

Market cap in millions BDT. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 8, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,575	3,572	2,398	1,816	1,698	1,422
Market Cap Growth	-21.25%	48.94%	32.07%	6.95%	19.38%	-44.98%
Enterprise Value	1,389	2,226	602	55	-52	-678
PE Ratio	-	-	-	7.78	5.92	5.46
PS Ratio	1.12	1.39	1.00	0.65	0.62	0.54
PB Ratio	2.91	4.04	3.12	2.37	2.23	1.88
P/OCF Ratio	-	-	-	-	460.98	-
EV/Sales Ratio	0.60	0.87	0.25	0.02	-	-
EV/EBITDA Ratio	-	50.95	-	0.14	-	-
EV/EBIT Ratio	-	114.07	-	0.16	-	-
Debt / Equity Ratio	0.01	0.01	0.00	0.00	-	-
Debt / EBITDA Ratio	-	0.09	-	0.00	-	-
Quick Ratio	7.50	6.17	7.30	7.81	9.42	12.77
Current Ratio	9.24	7.03	8.28	8.96	10.90	15.35
Asset Turnover	0.40	0.41	0.38	0.45	0.46	0.47
Return on Equity (ROE)	-22.13%	-6.89%	-28.20%	30.51%	37.77%	34.43%
Return on Assets (ROA)	-1.14%	0.19%	-1.10%	3.51%	3.97%	3.79%
Return on Capital (ROIC)	-8.03%	1.47%	-9.01%	28.61%	30.99%	28.10%
Earnings Yield	-7.10%	-1.59%	-9.03%	12.86%	16.89%	18.31%
Earnings Yield	-7.10%	-1.59%	-9.03%	12.86%	16.89%	18.31%
FCF Yield	-13.67%	-5.02%	-15.10%	-9.68%	-0.34%	-3.21%
Dividend Yield	1.40%	1.02%	-	3.14%	2.41%	-
Payout Ratio	-	-	-	16.01%	11.77%	13.01%
Total Shareholder Return	1.37%	1.02%	-	3.14%	2.41%	-

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.